Description

Gliutazon tablets 45 mg. №28

Ingredients:

Each tablet contains 45 mg of Gliutazon.

Dosage:

The recommended dosage is one tablet daily, or as directed by a healthcare professional.

Indications:

Gliutazon tablets are indicated for the treatment of type 2 diabetes mellitus. It helps to control blood sugar levels and improve insulin sensitivity.

Contraindications:

Do not use Gliutazon tablets if you have a history of liver disease or heart failure. Consult your doctor before starting this medication.

Directions:

Take one tablet orally with or without food, at the same time each day. Follow your healthcare provider’s instructions carefully.

Scientific Evidence:

Gliutazon, a thiazolidinedione, works by improving insulin sensitivity in the body. Studies have shown that it can effectively lower blood sugar levels and reduce HbA1c levels in patients with type 2 diabetes. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the long-term benefits of Gliutazon in improving glycemic control and reducing the risk of diabetic complications.

Additional Information:

It is important to monitor liver function tests regularly while taking Gliutazon tablets, as it can cause liver toxicity in some individuals. Inform your doctor of any unusual symptoms such as abdominal pain, dark urine, or jaundice. Gliutazon may interact with other medications, so disclose all your current medications to your healthcare provider before starting this treatment.

Pharmacological Effects: Gliutazon acts as an agonist for peroxisome proliferator-activated receptor gamma (PPAR-γ), which plays a key role in glucose and lipid metabolism. By activating this receptor, Gliutazon improves insulin sensitivity in peripheral tissues, reduces hepatic glucose production, and enhances glucose uptake in skeletal muscles.

Clinical Trials: In a comparative study published in Diabetes Care, Gliutazon was found to be more effective in improving insulin sensitivity and reducing fasting plasma glucose levels compared to other oral antidiabetic agents. The study concluded that Gliutazon can be a valuable treatment option for patients with type 2 diabetes who are inadequately controlled with other medications.